Tourette syndrome and medical treatment in Canada.
Self-report data were gathered from a national sample of over two hundred Canadian Tourette Syndrome (TS) patients. Included was previous use of stimulant medication and prior extended use of antihistamines for allergies or sinus condition. Patients were also asked information on Tourette Syndrome-precipitated hospitalization or boarding school placement, the type of physician treating them and on a five-point scale their level of satisfaction with their medical care. Results indicate that over 20% of TS patients have used stimulant medications and 30% have used antihistamine for extended periods. Many patients have spent time in psychiatric settings and most are under the care of psychiatrist or neurologist. Approximately 40% of TS patients reported being satisfied to very satisfied with the medical care they were receiving, and 20% having mixed feelings. Few patients receiving medical care were dissatisfied with their treatment.
Wand
R R
RR
Department of Psychiatry, St. Boniface General Hospital, Winnipeg, Manitoba, Canada.
Fulton
W A
WA
Shady
G A
GA
Champion
L M
LM
Hubka
G
G
D000293:Adolescent; D000328:Adult; D000662:Amphetamines / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications; D002170:Canada; D002648:Child; D002675:Child, Preschool; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007326:Institutionalization; D008297:Male; D008875:Middle Aged; D011795:Surveys and Questionnaires; D005879:Tourette Syndrome / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology
D000662:Amphetamines; D006634:Histamine H1 Antagonists